| 
             
			
			 "We thought they would want it to be in person or by email, but it 
			turned out that the phone was most preferred; it's quick and it also 
			gives them the chance to ask questions," said co-author Dr. Maria 
			Wei, director of the melanoma surveillance clinic at the University 
			of California, San Francisco (UCSF). 
			 
			Wei and colleagues surveyed 298 patients examined at melanoma 
			clinics at UCSF, the University of Pennsylvania and Duke University 
			to see how they wanted to be informed of their test results. 
			 
			On average, participants were about 54 years old. About half were 
			men and the group was predominantly white. Almost nine in 10 had a 
			previous history of melanoma and about one-third had a family 
			history of this type of skin cancer. 
			 
			The group was well-educated; about 34 percent went to graduate 
			school and roughly 48 percent went to college. 
			 
			Most patients in the study had either what's known as stage 0 
			melanoma, when the cancer hasn't grown deeper than the top layer of 
			skin, known as the epidermis, or stage 1, when the tumor is very 
			thin and less likely to spread. 
			
			  
			Before they knew if they would need biopsies, patients were asked 
			how they would want to receive biopsy results. About two-thirds 
			wanted to speak directly to their physician by phone, and another 20 
			percent preferred to return to the clinic to get results in person. 
			 
			Not many people wanted to get a voicemail though, an option 
			preferred by just 5 percent of participants, the same proportion who 
			said they'd like to get results by accessing an online patient 
			portal system. 
			 
			Less than 3 percent preferred email, and even fewer patients 
			expressed interest in receiving text messages. 
			 
			More than half of the study participants said they would make the 
			same choice whether the biopsy was positive or negative for cancer. 
			 
			Doctors also said phone calls work best, though they were less 
			likely to make the call themselves for a negative result. 
			 
			The researchers surveyed 84 physicians to get their take on the 
			ideal way to share test results. This group was younger, 43 years 
			old on average, and had typically been practicing medicine for about 
			11 years. 
			To deliver bad news, about 57 percent of doctors would pick up the 
			phone, compared with just 31 percent for good news. Their second 
			choice in either situation was to delegate the call to an assistant. 
			Like their patients, few favored email. 
			
            [to top of second column]  | 
            
             
  
				
			To some extent, people may have chosen the most familiar option. 
			Patients at Duke, where an online patient portal has been up and 
			running for longer, were most likely to choose this option, though 
			it was still their second choice after a phone call. Face-to-face 
			communication, the second choice at UCSF and UPenn, was preferred by 
			only 5.6 percent of patients at Duke. 
			 
			Limitations of the study include its small sample size and its focus 
			on academic medical centers, where patient populations can be 
			different from those at local clinics in the community, the 
			researchers note in JAMA Dermatology. Ethnic minorities and people 
			with limited English skills were not well-represented either, they 
			acknowledge. 
			And there’s no way to know if patients getting biopsies for other 
			forms of cancer would have the same set of preferences. 
			 
			Still, online portals and electronic communication are likely to 
			gain in popularity as they become more commonplace and simpler for 
			patients and physicians to navigate, said Dr. Jennifer Stein, a 
			dermatologist at New York University School of Medicine who wrote an 
			editorial accompanying the study. 
			 
			"As generations change and as technology changes, we may be moving 
			more in that direction," Stein said. "As we move toward more 
			patient-centered care, this shows that just asking a patient how 
			they want to receive information can be really illuminating." 
			
			  
			SOURCE: http://bit.ly/1EKVbkD 
			and http://bit.ly/1HmJm1J JAMA Dermatology, online April 1, 2015. 
			[© 2015 Thomson Reuters. All rights 
				reserved.] Copyright 2015 Reuters. All rights reserved. This material may not be published, 
			broadcast, rewritten or redistributed.  |